Scientists have found a new mechanism for the liver cell regeneration

August 25, 2017, Skolkovo Institute of Science and Technology
Credit: CC0 Public Domain

An international research collaborative has demonstrated for the first time the role of cholangiocytes (epithelial bile duct cells) in liver regeneration. The results of the study are highly promising for regenerative medicine and the fight against liver disease. The team's findings have been published in Nature.

The is one of the few organs in the human body that is capable of regenerating. In the event of as a result of trauma or chronic disease, the main liver cells—hepatocytes, which are responsible for all basic liver functions—are able to regenerate by dividing into new hepatocytes. Stimulation of liver regeneration is an acute problem for medical practitioners and researchers, but the details of this mechanism and whether other types of hepatic cells are involved in the process of the formation of new hepatocytes remains unclear.

An international group of scientists used transgenic mice as test subjects; in doing so, they managed to simulate liver damage common to humans. The experiment was carried out on two independent transgenic mouse models, within which the ability of hepatocytes to divide was intentionally reduced in order to evaluate the contribution of other liver cells to regeneration. As a result, it was shown that bile duct epithelial cells—cholangiocytes—are involved in the regeneration of hepatocytes. Also, the scientists suggest that the potential for regeneration in hepatocytes derived from cholangiocytes may be higher than in normal hepatocytes.

Yuri Kotelevtsev, Skoltech Professor and deputy director of the Skoltech Center for Translation Medcine, said, "A little over a year ago, I met with my colleagues from the University of Edinburgh to create joint scientific projects. I told them about how in our research center at Skoltech, under the guidance of Professor Victor Koteliansky, we managed to adjust the technology of liver gene knockdown. This technology has been well known for about seven years, but its application, in vivo, requires a high experimental level and is still only available in a few academic laboratories. It turned out that the laboratory of Professor Stuart Forbes was working on a problem in the solution of which knockdown could quickly confirm the hypotheses of the key role of cholangiocytes in . The contribution of Skoltech and MIT is that we created and provided lipid nanoparticles with siRNA to beta 1 integrin that blocked the expression of this gene in the hepatocytes in mice, and subsequent observations over the phenotype of the model obtained allowed for the identification of cholangiocytes, which are involved in the regeneration of the liver. Currently, the Scottish Center for Regenerative Medicine, under the leadership of Professor Forbes, is beginning work aimed at isolating and transplanting autologous cholangiocytes to patients with cirrhosis of the liver. We are now continuing the collaboration with Professor Forbes' lab. We are engaged in testing new target genes, the blocking of which could prevent or stabilize the processes associated with fibrosis and subsequent cirrhosis of the liver."

Explore further: Newly discovered cells regenerate liver tissue without forming tumors

More information: Raven, Alexander, Wei-Yu Lu, Tak Yung Man, Sofia Ferreira-Gonzalez, Eoghan O'Duibhir, Benjamin J. Dwyer, John P. Thomson, et al. "Cholangiocytes Act as Facultative Liver Stem Cells during Impaired Hepatocyte Regeneration." Nature 547, no. 7663 (July 20, 2017): 350–54. DOI: 10.1038/nature23015

Related Stories

Newly discovered cells regenerate liver tissue without forming tumors

August 13, 2015
The mechanisms that allow the liver to repair and regenerate itself have long been a matter of debate. Now researchers at University of California, San Diego School of Medicine have discovered a population of liver cells ...

New progress toward finding best cells for liver therapy

April 26, 2017
In a new study, researchers demonstrate successful transplantation of fetal rat liver cells to an injured adult rat liver. The work is an important step toward using transplanted cells to treat liver failure, which currently ...

Molecule's role in maintaining liver size and function revealed

August 1, 2017
For organs to maintain a steady state and fulfill their intended functions, the rates at which the cells within them multiply or die off need to be equal. This balance must also be adjusted when events such as an injury or ...

Liver progenitor cells are involved in the development of hepatic tumors

April 18, 2017
The malignant transformation of hepatocytes is the origin of most hepatocellular carcinomas, an aggressive type of liver cancer with high mortality rates. But these cells do not act alone. Research conducted by scientists ...

New genetic screen paves the way for long-sought treatments for liver disease

April 11, 2013
Chronic liver failure is a major health problem that causes about one million deaths around the world each year. A study published April 11th by Cell Press in the journal Cell reveals a new type of screen for identifying ...

Transplanted liver cells protect against liver failure after massive hepatectomy surgery

April 25, 2016
Liver failure often occurs after an extensive hepatectomy, which is the surgical resection of the liver. While liver cell transplantation is a useful therapy for acute liver failure after massive hepatectomy, when cells are ...

Recommended for you

RNA processing and antiviral immunity

December 14, 2018
The RIG-I like receptors (RLRs) are intracellular enzyme sentries that detect viral infection and initiate a first line of antiviral defense. The cellular molecules that activate RLRs in vivo are not clear.

Faster test for Ebola shows promising results in field trials

December 13, 2018
A team of researchers with members from the U.S., Senegal and Guinea, in cooperation with Becton, Dickinson and Company (BD), has developed a faster test for the Ebola virus than those currently in use. In their paper published ...

Drug targets for Ebola, Dengue, and Zika viruses found in lab study

December 13, 2018
No drugs are currently available to treat Ebola, Dengue, or Zika viruses, which infect millions of people every year and result in severe illness, birth defects, and even death. New research from the Gladstone Institutes ...

Urbanisation and air travel leading to growing risk of pandemic

December 13, 2018
Increased arrivals by air and urbanisation are the two main factors leading to a growing vulnerability to pandemics in our cities, a University of Sydney research team has found.

Researchers discover new interactions between Ebola virus and human proteins

December 13, 2018
Several new connections have been discovered between the proteins of the Ebola virus and human host cells, a finding that provides insight on ways to prevent the deadly Ebola virus from reproducing and could lead to novel ...

Faecal transplants, 'robotic guts' and the fight against deadly gut bugs

December 13, 2018
A simple compound found in our gut could help to stop dangerous bacteria behind severe, and sometimes fatal, hospital infections.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.